Corbus: Data shows ‘significant’ tumor growth inhibition with monoclonal antibody 10-Nov-2022 By Jane Byrne Corbus says new data shows its monoclonal antibody demonstrates robust pre-clinical anti-tumor activity alone and in combination with anti-PD-1 therapy.